NRx Pharmaceuticals, Inc.
NRXP
$2.75
$0.124.56%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 53.32% | 320.62% | -68.60% | -81.51% | -87.32% |
| Total Receivables | -- | -- | -- | 0.00% | 0.00% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -57.18% | -5.23% | 104.96% | -26.40% | -23.22% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -8.31% | -27.13% | -5.40% | -57.58% | -58.87% |
| Total Current Assets | -5.94% | 116.79% | -52.03% | -68.63% | -75.34% |
|
|
|||||
| Total Current Assets | -5.94% | 116.79% | -52.03% | -68.63% | -75.34% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -37.50% | -24.26% | -19.03% | 1,595.24% | 1,728.57% |
| Total Assets | -8.09% | 100.37% | -50.09% | -65.96% | -73.43% |
|
|
|||||
| Total Accounts Payable | -27.62% | -31.19% | -10.84% | 34.01% | 127.44% |
| Total Accrued Expenses | -16.31% | -5.37% | 224.19% | 8.73% | 3.73% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 28.79% | 23.87% | -86.40% | -69.71% | -39.72% |
| Total Finance Division Other Current Liabilities | 447.24% | 55,926.92% | 93,976.47% | 1,942.28% | 366.42% |
| Total Other Current Liabilities | 447.24% | 55,926.92% | 93,976.47% | 1,942.28% | 366.42% |
| Total Current Liabilities | 71.01% | 73.68% | 14.78% | 5.03% | 4.59% |
|
|
|||||
| Total Current Liabilities | 71.01% | 73.68% | 14.78% | 5.03% | 4.59% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 71.01% | 73.68% | 41.09% | 20.47% | 4.59% |
|
|
|||||
| Common Stock & APIC | 6.65% | 5.73% | 5.65% | 3.20% | 3.84% |
| Retained Earnings | -12.63% | -9.28% | -9.93% | -8.19% | -10.22% |
| Treasury Stock & Other | -- | -- | -- | -- | 86.36% |
| Total Common Equity | -93.65% | -66.97% | -97.88% | -202.60% | -554.95% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -93.65% | -66.97% | -97.88% | -202.60% | -554.95% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -93.65% | -66.97% | -97.93% | -202.75% | -554.95% |
|
|
|||||